NSF I/UCRC in Pharmaceutical Processing

普渡大学建议建立一个多大学的国家科学基金会工业/大学合作研究中心在药物加工。 伙伴大学是康涅狄格大学和波多黎各大学。 该中心的目的是探索和开发新的制药工艺技术，促进工业和学术科学家之间的合作研究项目，并促进跨学科的方法来培养学生在制药工艺研究和开发。 该中心的组织结构包括一个工业咨询委员会，由每个参与公司的一名成员组成，确定研究优先事项并批准中心的所有支出。 中心主任负责管理中心的日常运作，并与成员公司以及大学行政部门保持联系。 大学政策委员会确保研究生的研究是适当的程度的目标，教师的发展不会受到不利影响的参与中心，该中心的活动是按照大学的政策进行。 Ken Hemilich博士，默克公司药物研发部的退休执行董事，将担任该中心的外部评估员

The University of Purdue proposes to establish a multi-university National Science Foundation Industry/University Cooperative Research Center in Pharmaceutical Processing. Partner universities are the University of Connecticut and the University of Puerto Rico. The purposes of the Center are to explore and develop new technology for pharmaceutical processing, to foster collaborative research projects between industrial and academic scientists, and to promote an interdisciplinary approach to training students in pharmaceutical process research and development. The organizational structure of the Center comprises an Industrial Advisory Board, consisting of one member from each participating company, establishes research priorities and approves all spending by the Center. The Center Director manages day-to-day operation of the Center and acts as liaison with member companies as well as the University administration. The University Policy Committee assures that graduate student research is appropriate for the degree objective, that faculty development is not adversely affected by participation in the Center, and that Center activities are carried out in accordance with University policy. Dr. Ken Hemilich, retired Executive Director of Pharmaceutical Research and Development at Merck, will serve as external evaluator for the Center